Non-evidence-based antipsychotic drug prescribing in the treatment of adult schizophrenia
Introduction. The extent of combination antipsychotic prescribing (CAP), or polypharmacy, in the treatment of schizophrenia is high, with evidence of prevalence exceeding 40% nationally and 30% across Greater Manchester. CAP increases the incidence of adverse drug events and inadvertent high dosage,...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Manchester
2009
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501949 |